AzTrials
AzTrials

Quadriceps MuscleNCT04095442

Effect of Antibacterial Mouthwash on Muscle Function in Healthy Young Men and Women

A study testing Cepacol and Tom's Natural Mouthwash in people with Quadriceps Muscle, run by Indiana University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the effects of antibacterial mouthwash on muscle speed and power in healthy young men and women. We have previously demonstrated that drinking beetroot juice, a source of dietary nitrate and therefore nitric oxide, increases muscle function in this population. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Quadriceps Muscle
What is being tested?
Cepacol and Tom's Natural Mouthwash
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
32 participants
Where
1 siteUnited States
Study dates
1 Nov 2019to 20 Mar 2023
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Men and Women age 18-30 years old
  • No current use of mouthwash

Who cannot join

  • Men and Women <18 or 30> y of age
  • Unable to provide informed consent
  • Current users of mouthwash
  • Current antibiotic use
  • Current smokers
  • Currently pregnant or lactating
Show all 15Show fewer
  • Stage II hypertension (resting blood pressure >140/>90)
  • An answer of yes to any of the seven questions on the first page of the Physical Activity Readiness Questionnaire (PAR-Q) indicating that the subject is not physically ready for exercise without a medical exam. These exclusions include the following:
  • If participant's doctor has ever said that he/she has a heart condition and that he/she should only do physical activity recommended by a doctor
  • Pain in chest when doing physical activity
  • In past month, chest pain when not doing physical activity
  • If participant has ever lost balance because of dizziness or has ever lost consciousness
  • Bone or joint problem that could be made worse by change in physical activity
  • Currently on prescribed drugs for blood pressure or heart condition.
  • If the participant knows of any other reason why he/she should not do physical activity.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Indiana University School of Health and Human Sciences

    Indianapolis, Indiana, 46202

Other trials in United States

About this study

The purpose of this study is to determine the effects of antibacterial mouthwash on muscle speed and power in healthy young men and women. We have previously demonstrated that drinking beetroot juice, a source of dietary nitrate and therefore nitric oxide, increases muscle function in this population. Antibacterial mouthwash has been shown to interfere with the conversion of dietary nitrate to nitric oxide. We therefore hypothesize that it will diminish nitric oxide bioavailability and inhibit muscle contractility.

Read the detailed description

Study Visit One:

During an initial visit, subjects will complete the informed consent process, be instructed on the requirements of the study, and practice the exercise protocol (see below).

Study Visit Two:

Subjects will be tested after they have avoided exercise, caffeine, alcohol, chewing gum, and foods high in nitrate (e.g., spinach, beets, collard greens) for at least 24 hours. They will also be asked to not use any mouthwash products during this period. They will then provide provide a saliva sample for subsequent measurement of nitrate and nitrite concentrations and have their breath nitric oxide levels measured using a portable analyzer. The maximal knee extensor speed and power of their knee extensor muscles will then be measured using an isokinetic dynamometer. This machine can control the speed of movement while measuring the maximal force (torque) that a subject can voluntarily produce.

Subjects will then be randomly assigned to receive either an antibacterial mouthwash (Cepacol©, Reckitt Benckiser, Parsippany, NJ) or, as a control solution, an alcohol-free "natural" mouthwash (Tom's of Maine©, Kennebunk, ME). Participants will be asked to rinse their mouth as directed on the product's packaging for 30 s twice per day for 7 (+/-2) days and to record the usage of the mouthwash on a provided form. Subjects will then return for Study Visit 3 (see below). This is considered a single-blind study, which means that the investigators will not know what type of mouthwash a subject is receives.

Study Visit Three:

At the end of the treatment period, subjects will be asked to return to undergo the same procedures as described for Study Visit Two.

Being tested
Cepacol, Tom's Natural Mouthwash
Keywords
muscle power, nitric oxide, muscle speed, oral microbiome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CepacolDevice

    Twice-daily use of Cepacol per the manufacturer's guidelines

  • Tom's Natural MouthwashDevice

    Twice-daily use of Tom's Natural Mouthwash per the manufacturer's guidelines

Study groups in NCT04095442
Study groupRoleWhat they receive
CepacolActive comparatorNot described
Receives: Device: Cepacol
Tom's Natural MouthwashSham comparatorNot described
Receives: Device: Tom's Natural Mouthwash

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle Function

    Maximal knee extensor speed determined using isokinetic dynamometry

    Measured: 1 day

  2. Muscle Function

    Maximal knee extensor speed determined using isokinetic dynamometry

    Measured: 7 day

Secondary outcomes (4)
  1. Salivary Nitrate

    Salivary concentration of nitrate

    Measured: 1 day

  2. Salivary Nitrite

    Salivary concentration of nitrite

    Measured: 7 day

  3. Breath Nitric Oxide

    Breath nitric oxide level

    Measured: 1 day

  4. Breath Nitric Oxide

    Breath nitric oxide level

    Measured: 7 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2019
  2. Study start1 Nov 2019
  3. Primary completion20 Mar 2023
  4. Study completion20 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04095442
Sponsor's protocol ID
1907204336
Status last verified
Feb 2024
First submitted
16 Sep 2019
Last updated
18 Mar 2024
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Gallardo EJ, Zoughaib WS, Singhal A, Hoffman RL, Coggan AR. Pilot randomized trial of the effect of antibacterial mouthwash on muscle contractile function in healthy young adults. PLoS One. 2025 Feb 12;20(2):e0312961. doi: 10.1371/journal.pone.0312961. eCollection 2025.

    PubMed 39937800

Questions about this trial

What is this clinical trial studying?

A study testing Cepacol and Tom's Natural Mouthwash in people with Quadriceps Muscle, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 18 Mar 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle Function (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04095442, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in